S SignalIQ Pro
Mutual Funds › Sectoral › Bajaj Finserv Healthcare Fund - Direct Plan - Growth
Sectoral · Thematic

Bajaj Finserv Healthcare Fund - Direct Plan - Growth

Fund House: Bajaj Finserv Mutual Fund Plan: Direct · Growth Earliest NAV: 2024-12-30 Scheme Code: 153157
SignalIQ View Descriptive research · not a buy/sell recommendation
Sharpe (3Y)
0.43
Return per unit of risk · rf 6.5%
Sortino (3Y)
0.59
Downside-only Sharpe
Max Drawdown
-15.7%
Peak-to-trough · full history
Vol (3Y)
13.4%
Annualised σ of daily returns
Positive Days
55%
Smoothness proxy
This fund has delivered weak risk-adjusted returns over the last 3 years (Sharpe 0.43). Its worst peak-to-trough drop over the full history was 15.7% (modest drawdowns) between 2025-01-02 and 2025-02-28. About 55% of trading days closed up.
YTD
+25.1%
Calendar YTD
1 Year
+21.1%
Trailing 12 mo
3 Year
—
CAGR
5 Year
—
CAGR
10 Year
—
CAGR
Since Inception
—
CAGR (?y)
📈 NAV History
End-of-day NAV series from AMFI (via MFAPI.in).
🎯 Rolling-Return Consistency
Not enough NAV history yet to compute rolling windows. Fund needs at least 3 years on file.
🏁 Peer Comparison · Top in Sectoral
Scheme 1Y 3Y CAGR 5Y CAGR Latest NAV
HDFC Transportation and Logistics Fund
HDFC Mutual Fund
+6.9% +25.0% — —
SBI Healthcare Opportunities Fund
SBI Mutual Fund
+20.6% +24.5% +18.9% —
UTI - Healthcare Fund
UTI Mutual Fund
+16.3% +24.4% +16.5% —
LIC MF Infrastructure Fund
LIC Mutual Fund
+8.6% +24.1% +22.3% —
Franklin Asian Equity Fund
Franklin Templeton Mutual Fund
+35.2% +23.6% +10.0% —
LIC MF Healthcare Fund
LIC Mutual Fund
+15.4% +22.7% — —
Bajaj Finserv Healthcare Fund (this fund)
Bajaj Finserv Mutual Fund
+21.1% — — —
Disclaimer: Mutual fund investments are subject to market risks. Read all scheme related documents carefully before investing. Past performance is not indicative of future results. This page publishes descriptive rank-and-return analysis only — not personalised advice on which fund to buy. Trailing returns and rolling-window statistics are computed from AMFI's official daily NAV series. Research by Equity Alfa Analytics, SEBI Registered Research Analyst · INH000024985 · BSE RAASB Enlistment 6942.